Market Cap 6.22M
Revenue (ttm) 3.95M
Net Income (ttm) -24.99M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -632.66%
Debt to Equity Ratio 0.00
Volume 3,206,649
Avg Vol 2,079,406
Day's Range N/A - N/A
Shares Out 30.06M
Stochastic %K 68%
Beta 3.67
Analysts Strong Sell
Price Target $9.62

Company Profile

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States. The company is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tu...

Industry: Biotechnology
Sector: Healthcare
Phone: 678 384 7220
Fax: 678 384 7281
Address:
1900 Lake Park Drive, Suite 380, Smyrna, United States
BigGorillaG
BigGorillaG Feb. 15 at 12:37 AM
$SGD $DGLY $GOVX $BTCT 7<>
0 · Reply
GuruChartist
GuruChartist Feb. 13 at 11:27 PM
$GOVX Apologies to this thread. Had no idea that the company would do a financing. Just interested in what they are doing with neck and throat cancer due to a recently passed family member who went through the SOC. Would not wish it on anyone. Biotechs is the toughest sector out there.
0 · Reply
Bio_Be_Dirty
Bio_Be_Dirty Feb. 13 at 6:56 PM
$GOVX 1 2 monkeys coming for you
0 · Reply
luckysupernova
luckysupernova Feb. 13 at 3:31 PM
$GOVX 34% down from my last post telling you to short.
0 · Reply
AllandaleCapital
AllandaleCapital Feb. 13 at 3:06 PM
$GOVX this is what you get when you combine Roth, Armistice, Wainwright, sabby and maxim, live short interest 17.24%, CTB 107 OS: 2.13M Float: 2.13M Market Cap: $4.0M • Cash need is extreme (tracker shows ~0.4 months). This is a financing vehicle right now, not a “pipeline story.” Toxic Warrant/Note/Instrument blocks • February 2026 RDO Warrants (Series A-1 + Series A-2) 865,804 total warrants (432,902 + 432,902) @ $2.31 Underwriter: HC Wainwright Investors: not listed in your data Protection: undisclosed/unverified Interpretation: new paper on a tiny cap table. Even if the strike looks “above,” these deals usually come with structural leverage elsewhere (and your tracker flags the protection as unknown). Assume overhang until proven otherwise. • September 2025 RDO Warrant Stack 11,904,768 warrants (200% coverage) tied to the 9/30/2025 RDO @ $0.63 Underwriter: Roth Investors (listed): Armistice, Alto, Hudson Bay, Intracoastal, L1, Sabby Interpretation: this is the real anchor of dilution psychology. The warrant coverage is massive relative to today’s OS/float, and it sits on the books even if it’s way out-of-the-money post-splits. Traders will treat it like a ceiling. • Legacy Armistice warrant set (mostly high strikes) May 2024: 64,228 @ $42.00 (Roth; Armistice) July 2024: 86,800 @ $71.50 (Roth; Armistice) Aug 2024: 68,000 @ $125.00 (Roth; Armistice) Aug 2024 (2): 39,024 @ $125.00 (Roth; Armistice) Interpretation: economically irrelevant at this price unless corporate actions reset or reprice. But they still contribute to “overhead supply” optics. ATM / Equity line / Shelf blocks • September 2025 AGP ATM Total/Remaining: $3,116,227 Placement Agent: AGP Baby shelf restricted: Yes • March 2024 Shelf (active) Capacity: $100,000,000 Current raisable (IB6-limited): $4,924,812 Last banker: Roth Baby shelf restriction: Yes Interpretation: shelf headline is meaningless; IB6 is what matters. They can keep tapping, just in small bites, and they’ve shown they will. Completed dilutive events (with full banks/investors where provided) • 2026-02-13 RDO (S-3) 432,902 shares @ $2.31 865,804 warrants $1,000,000 raised Underwriter: HC Wainwright Investors: not listed in your data • 2025-09-30 RDO (S-3) 3,968,256 shares @ $0.63 11,904,768 warrants $2,500,001 raised Underwriter: Roth Investors: Armistice, Alto, Hudson Bay, Intracoastal, L1, Sabby • 2025-09-18 Used ATM (S-3) 337,511 shares @ $0.63 $220,000 raised Placement Agent: AGP • 2025-07-01 Underwritten S-1 9,200,000 shares @ $0.65 18,500,000 warrants $5,980,000 raised Underwriter: Roth Investors: not listed in your data • 2025-03-25 RDO (S-3) 3,435,115 shares @ $1.31 3,435,115 warrants $4,500,001 raised Underwriter: AGP • 2024-08-28 RDO (S-3) 975,610 shares @ $5.13 975,610 warrants $5,000,001 raised Underwriter: Roth Investors: Armistice • 2024-08-20 RDO (S-3) 1,700,000 shares @ $5.00 1,700,000 warrants $8,500,000 raised Underwriter: Roth Investors: Armistice • 2024-07-12 RDO (S-3) 1,085,000 shares @ $2.86 2,170,000 warrants $3,103,100 raised Underwriter: Roth Investors: Armistice • 2024-05-21 RDO (S-3) 802,844 shares 1,605,688 warrants $1,348,777 raised Underwriter: Roth Investors: Armistice • 2022-05-25 Private Placement 9,090,910 shares @ $1.65 9,090,910 warrants $15,000,002 raised Underwriter: HC Wainwright Investors: Armistice
0 · Reply
geniuscali
geniuscali Feb. 13 at 2:49 PM
$GOVX lol easiest short
0 · Reply
spat0707
spat0707 Feb. 13 at 2:46 PM
$GOVX what happened
0 · Reply
To_De_Moon
To_De_Moon Feb. 12 at 10:30 PM
$GOVX fuck David
0 · Reply
mkomlo0721
mkomlo0721 Feb. 12 at 10:01 PM
$GOVX -That filing is prior to the reverse split. This stock drop on 10,000 worth of trades after hours. That hedge fund owning 10% is a good thing. Bunch of dumb ass's making comments about diluting the shares.
0 · Reply
TraderManfromUK
TraderManfromUK Feb. 12 at 9:36 PM
$GOVX And there it is another big dip to continue screwing retail ‼️❌🚨 1.80 now !!!
0 · Reply
Latest News on GOVX
GeoVax Labs, Inc. (GOVX) Q3 2025 Earnings Call Transcript

Nov 13, 2025, 10:41 PM EST - 3 months ago

GeoVax Labs, Inc. (GOVX) Q3 2025 Earnings Call Transcript


GeoVax Labs, Inc. (GOVX) Q2 2025 Earnings Call Transcript

Jul 28, 2025, 7:43 PM EDT - 7 months ago

GeoVax Labs, Inc. (GOVX) Q2 2025 Earnings Call Transcript


GeoVax Labs, Inc. (GOVX) Q1 2025 Earnings Call Transcript

May 1, 2025, 8:58 PM EDT - 10 months ago

GeoVax Labs, Inc. (GOVX) Q1 2025 Earnings Call Transcript


GeoVax Labs, Inc. (GOVX) Q4 2024 Earnings Call Transcript

Mar 27, 2025, 8:53 PM EDT - 11 months ago

GeoVax Labs, Inc. (GOVX) Q4 2024 Earnings Call Transcript


GeoVax Labs, Inc. (GOVX) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 11:33 PM EST - 1 year ago

GeoVax Labs, Inc. (GOVX) Q3 2024 Earnings Call Transcript


GeoVax Labs, Inc. (GOVX) Q2 2024 Earnings Call Transcript

Aug 10, 2024, 6:15 AM EDT - 1 year ago

GeoVax Labs, Inc. (GOVX) Q2 2024 Earnings Call Transcript


GeoVax Labs, Inc. (GOVX) Q1 2024 Earnings Call Transcript

May 14, 2024, 8:01 PM EDT - 1 year ago

GeoVax Labs, Inc. (GOVX) Q1 2024 Earnings Call Transcript


GeoVax to Present at the 36th Annual Roth Conference

Mar 12, 2024, 9:00 AM EDT - 2 years ago

GeoVax to Present at the 36th Annual Roth Conference


GeoVax Labs, Inc. (GOVX) Q4 2023 Earnings Call Transcript

Mar 1, 2024, 2:34 AM EST - 2 years ago

GeoVax Labs, Inc. (GOVX) Q4 2023 Earnings Call Transcript


GeoVax to Present at the 2024 BIO CEO & Investor Conference

Feb 19, 2024, 9:00 AM EST - 2 years ago

GeoVax to Present at the 2024 BIO CEO & Investor Conference


GeoVax Announces Multiple Patent Issuances and Allowances

Feb 13, 2024, 9:00 AM EST - 2 years ago

GeoVax Announces Multiple Patent Issuances and Allowances


GeoVax Announces Issuance of Malaria Vaccine Patent

Jan 3, 2024, 9:00 AM EST - 2 years ago

GeoVax Announces Issuance of Malaria Vaccine Patent


GeoVax to Participate in Upcoming December Investor Events

Nov 29, 2023, 9:00 AM EST - 2 years ago

GeoVax to Participate in Upcoming December Investor Events


GeoVax Labs, Inc. (GOVX) Q3 2023 Earnings Call Transcript

Nov 8, 2023, 9:26 PM EST - 2 years ago

GeoVax Labs, Inc. (GOVX) Q3 2023 Earnings Call Transcript


GeoVax Receives Notice of Allowance for HIV Vaccine Patent

Oct 5, 2023, 9:00 AM EDT - 2 years ago

GeoVax Receives Notice of Allowance for HIV Vaccine Patent


BigGorillaG
BigGorillaG Feb. 15 at 12:37 AM
$SGD $DGLY $GOVX $BTCT 7<>
0 · Reply
GuruChartist
GuruChartist Feb. 13 at 11:27 PM
$GOVX Apologies to this thread. Had no idea that the company would do a financing. Just interested in what they are doing with neck and throat cancer due to a recently passed family member who went through the SOC. Would not wish it on anyone. Biotechs is the toughest sector out there.
0 · Reply
Bio_Be_Dirty
Bio_Be_Dirty Feb. 13 at 6:56 PM
$GOVX 1 2 monkeys coming for you
0 · Reply
luckysupernova
luckysupernova Feb. 13 at 3:31 PM
$GOVX 34% down from my last post telling you to short.
0 · Reply
AllandaleCapital
AllandaleCapital Feb. 13 at 3:06 PM
$GOVX this is what you get when you combine Roth, Armistice, Wainwright, sabby and maxim, live short interest 17.24%, CTB 107 OS: 2.13M Float: 2.13M Market Cap: $4.0M • Cash need is extreme (tracker shows ~0.4 months). This is a financing vehicle right now, not a “pipeline story.” Toxic Warrant/Note/Instrument blocks • February 2026 RDO Warrants (Series A-1 + Series A-2) 865,804 total warrants (432,902 + 432,902) @ $2.31 Underwriter: HC Wainwright Investors: not listed in your data Protection: undisclosed/unverified Interpretation: new paper on a tiny cap table. Even if the strike looks “above,” these deals usually come with structural leverage elsewhere (and your tracker flags the protection as unknown). Assume overhang until proven otherwise. • September 2025 RDO Warrant Stack 11,904,768 warrants (200% coverage) tied to the 9/30/2025 RDO @ $0.63 Underwriter: Roth Investors (listed): Armistice, Alto, Hudson Bay, Intracoastal, L1, Sabby Interpretation: this is the real anchor of dilution psychology. The warrant coverage is massive relative to today’s OS/float, and it sits on the books even if it’s way out-of-the-money post-splits. Traders will treat it like a ceiling. • Legacy Armistice warrant set (mostly high strikes) May 2024: 64,228 @ $42.00 (Roth; Armistice) July 2024: 86,800 @ $71.50 (Roth; Armistice) Aug 2024: 68,000 @ $125.00 (Roth; Armistice) Aug 2024 (2): 39,024 @ $125.00 (Roth; Armistice) Interpretation: economically irrelevant at this price unless corporate actions reset or reprice. But they still contribute to “overhead supply” optics. ATM / Equity line / Shelf blocks • September 2025 AGP ATM Total/Remaining: $3,116,227 Placement Agent: AGP Baby shelf restricted: Yes • March 2024 Shelf (active) Capacity: $100,000,000 Current raisable (IB6-limited): $4,924,812 Last banker: Roth Baby shelf restriction: Yes Interpretation: shelf headline is meaningless; IB6 is what matters. They can keep tapping, just in small bites, and they’ve shown they will. Completed dilutive events (with full banks/investors where provided) • 2026-02-13 RDO (S-3) 432,902 shares @ $2.31 865,804 warrants $1,000,000 raised Underwriter: HC Wainwright Investors: not listed in your data • 2025-09-30 RDO (S-3) 3,968,256 shares @ $0.63 11,904,768 warrants $2,500,001 raised Underwriter: Roth Investors: Armistice, Alto, Hudson Bay, Intracoastal, L1, Sabby • 2025-09-18 Used ATM (S-3) 337,511 shares @ $0.63 $220,000 raised Placement Agent: AGP • 2025-07-01 Underwritten S-1 9,200,000 shares @ $0.65 18,500,000 warrants $5,980,000 raised Underwriter: Roth Investors: not listed in your data • 2025-03-25 RDO (S-3) 3,435,115 shares @ $1.31 3,435,115 warrants $4,500,001 raised Underwriter: AGP • 2024-08-28 RDO (S-3) 975,610 shares @ $5.13 975,610 warrants $5,000,001 raised Underwriter: Roth Investors: Armistice • 2024-08-20 RDO (S-3) 1,700,000 shares @ $5.00 1,700,000 warrants $8,500,000 raised Underwriter: Roth Investors: Armistice • 2024-07-12 RDO (S-3) 1,085,000 shares @ $2.86 2,170,000 warrants $3,103,100 raised Underwriter: Roth Investors: Armistice • 2024-05-21 RDO (S-3) 802,844 shares 1,605,688 warrants $1,348,777 raised Underwriter: Roth Investors: Armistice • 2022-05-25 Private Placement 9,090,910 shares @ $1.65 9,090,910 warrants $15,000,002 raised Underwriter: HC Wainwright Investors: Armistice
0 · Reply
geniuscali
geniuscali Feb. 13 at 2:49 PM
$GOVX lol easiest short
0 · Reply
spat0707
spat0707 Feb. 13 at 2:46 PM
$GOVX what happened
0 · Reply
To_De_Moon
To_De_Moon Feb. 12 at 10:30 PM
$GOVX fuck David
0 · Reply
mkomlo0721
mkomlo0721 Feb. 12 at 10:01 PM
$GOVX -That filing is prior to the reverse split. This stock drop on 10,000 worth of trades after hours. That hedge fund owning 10% is a good thing. Bunch of dumb ass's making comments about diluting the shares.
0 · Reply
TraderManfromUK
TraderManfromUK Feb. 12 at 9:36 PM
$GOVX And there it is another big dip to continue screwing retail ‼️❌🚨 1.80 now !!!
0 · Reply
TraderManfromUK
TraderManfromUK Feb. 12 at 8:38 PM
$GOVX DISGUSTING Mfckers .. Dilution scam hits another new lows ‼️❌🚨
0 · Reply
Ueberschlaefer
Ueberschlaefer Feb. 12 at 5:01 PM
$GOVX zack's research loves it! gave a ridiculous PT of 2-300 the other day. it's a pure scam, hundreds of millions burned up over decades. never produced a retail product. it should be investigated for fraud, but this is america, so boomer fraudsters run the place.
1 · Reply
BioGLovesMe
BioGLovesMe Feb. 12 at 2:56 PM
$GOVX Sheesh I just did more research on this junk bio and it is quite sad. Thanks to @GuruChartist for coming over to the other junk bio I follow (CVM) to give me my laugh of the day. I would love to know the bull "thesis" for "investing" in this junk bio that's been pre-revenue for close to 30 years now.
0 · Reply
GuruChartist
GuruChartist Feb. 12 at 1:15 PM
$GOVX Two research reports are out on Geovax : ​Median Target Price:$12.00 ▲(370.59% Upside) Based on 2 Wall Street analysts offering 12 month price targets for GeoVax Labs in the last 3 months. The average price target is $12.00 with a high forecast of $14.00 and a low forecast of $10.00. The average price target represents a 370.59% change from the last price of $2.55.EDIA $12.00 ▲(370.59% Upside) Based on 2 Wall Street analysts offering 12 month price targets for GeoVax Labs in the last 3 months. The average price target is $12.00 with a high forecast of $14.00 and a low forecast of $10.00. The average price target represents a 370.59% change from the last price of $2.55.
0 · Reply
luckysupernova
luckysupernova Feb. 11 at 11:42 PM
$GOVX chump
0 · Reply
GuruChartist
GuruChartist Feb. 11 at 10:17 PM
$CVM Neck and throat cancer is a horrible diagnosis. If the Standard of Care (SOC) for these cancers could change using the immune system, it would shift the prgnosis for these patients dramatically. $GOVX is another biotech doing work on these cancers too.
1 · Reply
DeezNuttz
DeezNuttz Feb. 11 at 2:53 PM
0 · Reply
IEATBEEF
IEATBEEF Feb. 10 at 2:22 PM
$GOVX fuck this company
0 · Reply
DipRider
DipRider Feb. 9 at 12:22 PM
$GOVX is a biotech (GeoVax Labs) developing vaccines and immunotherapies; it is a clinical-stage company with a focus on infectious diseases and cancer, both high-risk development areas.
1 · Reply
DeezNuttz
DeezNuttz Feb. 7 at 11:21 PM
0 · Reply
FeliciaMath
FeliciaMath Feb. 6 at 2:50 PM
$GOVX sold at 2.55 (lost $672/34%)
0 · Reply
Lion0fWallSt
Lion0fWallSt Feb. 5 at 6:47 PM
$SLS $ATOS $GOVX $SOL.X $COIN Mr. Calvin is about to catch his 4th bag
0 · Reply